2m 2m 2m 2m 2m 2m 2m
ALIGOS THERAPT (ALGS)
NASDAQ
$4.67+$0.44 (+10.43%)
Price as of Aug 03, 2026 11:30 AM EDT- $22.8MMarket Cap
- -43.30%1-Year Change
- BiotechnologyIndustry
ALIGOS THERAPT (ALGS)
$4.67+$0.44 (+10.43%)
ALGS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.23 | ||
Change | -$0.09 (-2.08%) | ||
Open | $4.46 | ||
High | $4.46 | ||
Low | $4.15 | ||
Previous Close | $4.32 | ||
Volume | 49,132 | ||
30-Day Average Volume | 289,052 | ||
1-Week Change | 3.68% | ||
1-Month Change | -26.69% | ||
1-Year Change | -43.30% | ||
3-Year Change | -80.99% | ||
5-Year Change | -98.84% | ||
Fundamentals | |||
Shares Outstanding | 5.4M | ||
Total Assets | $64.6M | ||
Market Cap | $22.8M | ||
Enterprise Value | -$7.2M | ||
Period: QTR TTM FY | |||
Revenue | $2.8M | ||
Net Income | -$23.0M | ||
Free Cash Flow | -$23.1M | ||
EBIT | -$22.7M | ||
EBITDA | -$22.4M | ||
Net Working Capital | $36.3M | ||
EPS | -$2.21 | ||
Enterprise Value/EBITDA | 0 | ||
Enterprise Value/Revenue | -3 | ||
P/B | 1 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 08/19/2024 | ||
Earnings & Revenue